Community-based Neuroendocrine Tumor (NET) Research Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

May 13, 2020

Study Completion Date

May 13, 2020

Conditions
Gastroenteropancreatic Neuroendocrine Tumors
Trial Locations (12)

45230

Oncology Hematology Care, Inc., Cincinnati

60005

Illinois Cancer Specialists, Arlington Heights

75231

Texas Oncology - Dallas Presbyterian Hospital, Dallas

75246

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas

75702

Texas Oncology, Houston

Texas Oncology-Tyler, Tyler

76210

Texas Oncology - Denton South, Denton

77598

Texas Oncology - Deke Slayton Cancer Center, Webster

77702

Texas Oncology - Beaumont, Mamie McFaddin Ward Cancer Center, Beaumont

80218

Rocky Mountain Cancer Centers, Denver

86336

Arizona Oncology Associates, Sedona

98902

Yakima Valley Memorial Hospital/North Star Lodge, Yakima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ipsen

INDUSTRY